Home
Ani Pharmaceuticals

Ani Pharmaceuticals Market Share Analysis for November 2025

ani pharmaceuticals is an integrated specialty pharmaceutical company developing, manufacturing, and marketing high quality branded and generic prescription pharmaceuticals.

Health > Biotechnology and Pharmaceuticals

Domainanipharmaceuticals.com

Year Founded1996

Employees501 - 1000

Annual Revenue$200M - $500M

Ani Pharmaceuticals

Showing Ani Pharmaceuticals's traffic and engagement information for its main website (including company regionals)

anipharmaceuticals.com
alimerasciences.com
novitiumpharma.com

See more website traffic and engagement information

Ani Pharmaceuticals Revenue up to November 2025 is 200M - 500M

revenue generated by Ani Pharmaceuticals top domains

Ani Pharmaceuticals top domains revenue over 3 years

Revenue for Ani Pharmaceuticals top domains

anipharmaceuticals.com200M - 500M

alimerasciences.com50M - 75M

novitiumpharma.com15M - 25M

See more with Sales Intelligence

Total visits to Ani Pharmaceuticals's top domains

Understand Ani Pharmaceuticals market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

anipharmaceuticals.com8K

alimerasciences.com25

novitiumpharma.com1.1K

See more with Sales Intelligence

Avg. visit duration in Ani Pharmaceuticals's top domains

Analyze Ani Pharmaceuticals engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

anipharmaceuticals.com00:00:34

novitiumpharma.com00:00:01

See more with Sales Intelligence

Avg. pageviews on Ani Pharmaceuticals's top domains

See how Ani Pharmaceuticals keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

anipharmaceuticals.com2.52

alimerasciences.com1.03

novitiumpharma.com1.34

See more with Sales Intelligence

Ani Pharmaceuticals top competitors by domain

Top similar sites in November 2025, ranked by their affinity

otsuka.comCompany NameOtsuka Holdings Co., Ltd.Employees> 10001HQJapan, Chiyoda-kuAnnual revenue> $1BTotal visits1.9MHealth > Biotechnology and Pharmaceuticals

Top technologies used by Ani Pharmaceuticals

These are the website technologies, by industry, used by Ani Pharmaceuticals top domains

Content Management System (3)

WordPress

Widget (3)

reCAPTCHA

Advertising (2)

Google Adsense

Marketing (2)

Google Marketing Platform

More Technologies

7

See all

News & Signals from Ani Pharmaceuticals

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsANI Pharmaceuticals, Inc. launched Pentoxifylline Extended-Release Tablets, USP 400 mg on Jan 23rd '24.On January 23, 2024, ANI Pharmaceuticals unveiled its Pentoxifylline Extended-Release (ER) Tablets, USP 400 mg, offering a generic alternative to Trental(R).

NewsANI Pharmaceuticals, Inc. attends event 2025 Jefferies Global Healthcare Conference.PRINCETON, N.J., May 27, 2025 (GLOBE NEWSWIRE) - ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive Officer, will present at the 2025 Jefferies Global Healthcare Conference in New York City as follows:

NewsANI Pharmaceuticals, Inc. attends event H.C. Wainwright 3rd Annual BioConnect Investor Conference.PRINCETON, N.J., May 12, 2025 (GLOBE NEWSWIRE) - ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive Officer, and Stephen Carey, Chief Financial Officer, will present at the H.C. Wainwright 3rd Annual BioConnect Investor Conference at NASDAQ as follows: